Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)Young Kwang Chae, Francis J. Giles, Jaehyuk Choi et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 468